3.88
Neuronetics Inc (STIM) 最新ニュース
Neuronetics Reports 2024 Financial Results and Strategic Advances - MSN
Transcranial Magnetic Stimulator Market to Witness Remarkable - openPR.com
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression - MSN
Even though Neuronetics (NASDAQ:STIM) has lost US$30m market cap in last 7 days, shareholders are still up 130% over 5 years - simplywall.st
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression - The Manila Times
Major Insurance Breakthrough: NeuroStar's Teen Depression Treatment Now Covered for 15 Million Lives - Stock Titan
Neuronetics Revises Financial Results for Q4 and Full Year 2024 - MSN
Neuronetics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs (NASDAQ:STIM) - Seeking Alpha
Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results - The Manila Times
Neuronetics Some Non-Cash Revisions Made To Financial Statements Related To Co's Acquisition Of Greenbrook Tms & Shares Outstanding In Q4 - Marketscreener.com
Neuronetics Updates Financial Results: Q4 Losses Deepen After Greenbrook Deal Review - Stock Titan
Transcranial Magnetic Stimulator Market Is Booming So Rapidly - openPR.com
This Penny Stock Is Up 170% in 2025 and Analysts Think It Can Rally Further From Here - The Globe and Mail
FDA Clears NeuroStar's TMS Therapy for Adolescents with Major Depressive Disorder - MSN
While private equity firms own 38% of Neuronetics, Inc. (NASDAQ:STIM), retail investors are its largest shareholders with 43% ownership - Yahoo
Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet - Yahoo Finance
Neuronetics Inc (STIM) Q4 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Transcranial Magnetic Stimulator Market Positioned - openPR
Neuronetics’ SWOT analysis: merger synergies boost growth prospects for stock - Investing.com India
Earnings call transcript: Neuronetics Q4 2024 sees revenue growth, stock rises - Investing.com Australia
Neuronetics, Inc. to Host Earnings Call - ACCESS Newswire
William Blair Increases Earnings Estimates for Neuronetics - Defense World
Neuronetics Inc (STIM) Reports 8% Revenue Growth in Q3 2023 - GuruFocus.com
Neuronetics CFO Stephen Furlong sells $8,364 in stock - Investing.com India
Neuronetics (NASDAQ:STIM) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
(STIM) Technical Data - news.stocktradersdaily.com
Neuronetics executive sells shares worth $1,688 By Investing.com - Investing.com Canada
Neuronetics executive sells shares worth $1,688 - Investing.com India
Neuronetics CFO Stephen Furlong sells $8,364 in stock By Investing.com - Investing.com UK
Neuronetics, Inc.'s (NASDAQ:STIM) Shares Leap 69% Yet They're Still Not Telling The Full Story - Simply Wall St
Transcranial Magnetic Stimulator Market Growth and Future - openPR
Neuronetics’ Earnings Call: Growth Amid Challenges - TipRanks
Neuronetics Grants Inducement Awards to New Employees - MSN
Neuronetics, Inc. (NASDAQ:STIM) Q4 2024 Earnings Call Transcript - MSN
Neuronetics stock holds Market Outperform amid merger growth By Investing.com - Investing.com Canada
Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... By GuruFocus - Investing.com Canada
Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... - Yahoo Finance
Neuronetics’ Strategic Merger with Greenbrook TMS Fuels Growth and Positive Outlook - TipRanks
Neuronetics Reports Growth Amid Strategic Acquisitions - TipRanks
Canaccord raises Neuronetics stock target to $8, maintains buy rating By Investing.com - Investing.com Australia
Canaccord raises Neuronetics stock target to $8, maintains buy rating - Investing.com India
Neuronetics stock soars to 52-week high, hits $5.08 By Investing.com - Investing.com Canada
大文字化:
|
ボリューム (24 時間):